Regent’s Park Heart Clinics Ltd. (Regent’s Park), an independent healthcare company specialising in the diagnosis and treatment of heart disease, today announced that it has been awarded a Framework Agreement by the NHS Purchasing and Supply Agency (PASA) for the supply of mobile cardiac catheterisation laboratories and services across NHS trusts and health authorities in England. The Framework Agreement has been awarded for three years, commencing from 1st October 2003, with an option to extend up to 24 months.
Dr. Ohri, Chief Executive of Regent’s Park, said, “This award is great news for Regent’s Park and a welcome endorsement of our dedicated healthcare focus. Despite fierce competition we have confirmed our position as one of the leading players in the healthcare services marketplace for cardiovascular disease. The Framework Agreement enables NHS organisations’ throughout England to purchase our services with the knowledge that we have been thoroughly vetted, both in terms of technical capability and financial security”.
He added, “We share PASA’s dedication to continuous improvement of purchasing and supply, and recognise the essential role that professional procurement needs to have in achieving value for money and service benefits, which impact directly on the quality of patient care and service delivery. By evaluating suppliers to ensure they are of the necessary calibre to supply solutions to the NHS, and negotiating favourable terms for payment, support and implementation, PASA will undoubtedly save NHS Trusts and Authorities both time and money. For us it streamlines the tender and evaluation process and makes it easier to provide these institutions with the specialist services that they need to enhance their cardiovascular product offering, improve efficiency and reduce costs.”
The NHS Purchasing and Supply Agency is an executive agency of the Department of Health and contracts across England for products and services that are strategically critical to the NHS. Wherever possible it uses its aggregated purchasing power to negotiate more favourable contractual and financial terms than would otherwise not necessarily be agreed for individual projects. It works with approximately 350 NHS trusts and health authorities across England, managing national purchasing contracts and influencing an annual NHS spend on goods and services of over £2.6 billion. Its role is to act as a centre of excellence in purchasing and supply matters, and to facilitate best practice and effective purchasing decisions by the NHS. As an integral part of the Department of Health the agency is in a key position to advise on policy and the strategic direction of procurement, and its impact on healthcare, across the NHS.
Regent’s Park is an independent company dedicated to creating world-class centres for the diagnosis and treatment of heart disease. The company develops, owns and operates diagnostic and treatment facilities focusing exclusively on cardiovascular disease in partnership with leading hospitals and groups of cardiologists across the United Kingdom. The company was founded in 2002 to pioneer joint ventures with the NHS across the field of cardiac services, delivering expertise, quality and innovation in one value for money package.
Regent’s Park prides itself on its ability to deliver high quality, cost effective cardiac care, through excellent service, efficient operations management, well trained staff, and uncompromising professionalism.
The Regent’s Park guiding philosophy is that every patient with heart disease should have access to healthcare of a world-class standard.